erythromycin has been researched along with amikacin in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (26.32) | 18.7374 |
1990's | 8 (14.04) | 18.2507 |
2000's | 16 (28.07) | 29.6817 |
2010's | 16 (28.07) | 24.3611 |
2020's | 2 (3.51) | 2.80 |
Authors | Studies |
---|---|
Au, TK; Chan, EW; Chan, RC; Chin, ML; Chow, VC; Fung, DK; Hawkey, PM | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Bucki, R; Byfield, FJ; Cruz, K; Diamond, SL; Fein, DE; Janmey, PA; Kulakowska, A; Leszczynska, K; Namiot, A; Namiot, Z; Savage, PB; Won, E | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Dhamdhere, G; Krishnamoorthy, G; Zgurskaya, HI | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Granatek, AP; Nunning, BC; Ricci, RA | 1 |
Blech, MF; Hartemann, P; Imbs, MA | 1 |
Garcia-Rodriguez, JA; Martin-Luengo, F | 1 |
Spaepen, J; Vandepitte, J; Verbist, L | 1 |
Busch, DF; Finegold, SM; Sutter, VL | 1 |
Song, JF; Tang, MZ; Wang, MR | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
Armstrong, D; Brown, IN; Brown, S; Dale, JW; Edwards, FF; Felder, MS; Ollar, RA | 1 |
el-Nakeeb, MA; Fanaki, NH | 1 |
De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C | 1 |
Chan, CH; Chan, JK; Lim, WW; Wong, KF | 1 |
Bollet, C; de Micco, P; Gevaudan, MJ; Gulian, C; Mallet, MN | 1 |
Bermudez, LE; Young, LS | 1 |
de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
Bullen, MG; Silcox, VA; Swenson, JM; Wallace, RJ | 1 |
Prescott, JF; Sweeney, CR | 1 |
Hayasaka, S; Shiono, T | 1 |
Cavanagh, HD; Finton, RJ; Goodman, RA; Newman, PE; Waring, GO; Wilson, LA; Wright, J | 1 |
Blaser, MJ; Wang, WL | 1 |
Ferrieri, P; Johnson, DE; Mitchell, C; Munson, D; Speert, DP; Thompson, TR; Wannamaker, LW | 1 |
Sanders, WJ; Wolinsky, E | 1 |
Kitade, M; Moritaka, T; Nakanishi, N; Ueda, N | 1 |
Miller, SD | 1 |
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
Cheze, S; De Puyfontaine, O; Leporrier, M; Macro, M; Pan, B; Reman, O; Toudic, F | 1 |
Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
Alvirez-Freites, E; Cynamon, MH; DeStefano, MS; Yeo, AE | 1 |
Catasus, CT; Elliot, SB; Kelmer, G; Saxton, AM | 1 |
Bucki, R; Janmey, PA; Leszczyńska, K; Namiot, A | 1 |
Gao, J; Han, B; He, JZ; Hou, RG; Li, SM; Luo, LP; Su, JL; Yu, FQ; Zhang, HQ | 1 |
Fiegel, J; Sommerfeld Ross, S | 1 |
Arora, D; Fysal, N; Hafiz, KA; Jose, S; Kulshrestha, R; Vasudevan, S | 1 |
Adamski, P; Borszewska-Kornacka, M; Bulanda, M; Chmielarczyk, A; Gulczyńska, E; Helwich, E; Kordek, A; Lauterbach, R; Pobiega, M; Romaniszyn, D; Różańska, A; Wójkowska-Mach, J | 1 |
Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
Barzegar, KEF; Barzegar, PEF; Farjanikish, G; Hayati, FZ; Ranjbar, R; Tahmasebi, E; Tebyaniyan, H; Yazdanian, M | 1 |
3 review(s) available for erythromycin and amikacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)].
Topics: Air Microbiology; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Epidemiologic Methods; Erythromycin; Gentamicins; Humans; Lincomycin; Polymyxins; Serratia marcescens; Sisomicin; Soil Microbiology; Tetracyclines; Tobramycin; Water Microbiology | 1979 |
Treatment of Corynebacterium equi pneumonia of foals: a review.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bronchopneumonia; Chloramphenicol; Corynebacterium Infections; Drug Combinations; Drug Therapy, Combination; Erythromycin; Horses; Humans; Rifampin; Sulfadiazine; Trimethoprim | 1985 |
2 trial(s) available for erythromycin and amikacin
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Evaluation of indwelling intravenous catheters for the regional perfusion of the limbs of horses.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Catheters, Indwelling; Erythromycin; Horses; Infusions, Intravenous; Saphenous Vein; Tennessee; Veins; Veterinary Drugs | 2009 |
52 other study(ies) available for erythromycin and amikacin
Article | Year |
---|---|
High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Streptococcus | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Bacterial Infections; Biofilms; Cathelicidins; Cattle; Cells, Cultured; Dexamethasone; Drug Design; Humans; In Vitro Techniques; Interleukins; Macrophages; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Pseudomonas aeruginosa; Receptors, Glucocorticoid; Spermine; Staphylococcus aureus | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Erythromycin; Escherichia coli; Glutathione; Kanamycin; Microbial Sensitivity Tests; Novobiocin; Spermidine | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Physical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions - part III.
Topics: Amikacin; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Incompatibility; Drug Stability; Erythromycin; Injections, Intravenous; Kanamycin; Lincomycin; Novobiocin; Penicillins; Polymyxins; Solutions; Tetracyclines; Time Factors; Vancomycin | 1976 |
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.
Topics: Amikacin; Doxycycline; Erythromycin; Humans; Kanamycin; Mycobacterium; Mycobacterium Infections | 1978 |
In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Chloramphenicol; Cross Infection; Erythromycin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Rifampin; Serratia marcescens; Sputum; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Urine; Wound Infection | 1976 |
Activity of combinations of antimicrobial agents against Bacteroides fragilis.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Carbenicillin; Cefoxitin; Chloramphenicol; Clindamycin; Drug Combinations; Drug Interactions; Drug Synergism; Erythromycin; Metronidazole; Penicillins; Tetracycline | 1976 |
[Resistant rate to antibiotics in Tian Tan Hospital for 3 years].
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gentamicins; Klebsiella pneumoniae; Methicillin Resistance; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures.
Topics: Amikacin; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1991 |
A reliable two-hour Staphylococcus plate assay of rifampicin, erythromycin, lincomycin, chloramphenicol and amikacin in human sera.
Topics: Amikacin; Anti-Bacterial Agents; Biological Assay; Chloramphenicol; Drug Resistance, Microbial; Erythromycin; Humans; Lincomycin; Microbial Sensitivity Tests; Rifampin; Sensitivity and Specificity; Staphylococcus aureus | 1991 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry | 1991 |
Psittacosis-associated hemophagocytic syndrome.
Topics: Amikacin; Bone Marrow Examination; Carbenicillin; Erythromycin; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Middle Aged; Psittacosis | 1991 |
[Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
Topics: Amikacin; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium; Mycobacterium avium Complex; Rifabutin; Rifamycins | 1989 |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
Topics: Amikacin; Azithromycin; Cells, Cultured; Drug Interactions; Erythromycin; Humans; Leucomycins; Macrophage Activation; Macrophages; Mycobacterium avium Complex; Tumor Necrosis Factor-alpha | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Combinations; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Sulfisoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Aminoglycoside antibiotics and lysosomal enzymes of human tears.
Topics: Acetylglucosaminidase; Acid Phosphatase; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Depression, Chemical; Dibekacin; Erythromycin; Gentamicins; Hexosaminidases; Humans; Kanamycin; Muramidase; Sulbenicillin; Tears; Tobramycin | 1985 |
A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures.
Topics: Aged; Ambulatory Care Facilities; Amikacin; Cross Infection; Erythromycin; Female; Humans; Keratitis; Male; Mycobacterium Infections | 1984 |
Campylobacter infections in human beings.
Topics: Amikacin; Campylobacter; Campylobacter fetus; Campylobacter Infections; Cefazolin; Erythromycin; Feces; Female; Humans; Middle Aged | 1980 |
Mycobacterium chelonei septicemia in a premature infant.
Topics: Amikacin; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1980 |
In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Erythromycin; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Tetracyclines | 1980 |
[A case of cystic fibrosis in a Japanese student].
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cystic Fibrosis; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Japan; Male; Pseudomonas Infections; Quinolones; Respiratory Tract Infections | 1995 |
Madura foot: treatment of Nocardia nova infection with antibiotics alone.
Topics: Administration, Oral; Adult; Amikacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Foot Bones; Foot Dermatoses; Humans; Infusions, Intravenous; Nocardia; Nocardia Infections; Obesity, Morbid; Severity of Illness Index; Treatment Outcome | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
[Concomitant pulmonary nocardiosis and Hodgkin's disease: importance of long-term treatment].
Topics: Adult; Amikacin; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Erythromycin; Hodgkin Disease; Humans; Imipenem; Long-Term Care; Lung Diseases; Male; Minocycline; Nocardia Infections | 2002 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Nocardia; Sampling Studies; Sensitivity and Specificity | 2004 |
Modulation of exogenous antibiotic activity by host cathelicidin LL-37.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Drug Synergism; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2010 |
Antibiotic resistance of Streptococcus agalactiae from cows with mastitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cattle; China; Drug Resistance, Bacterial; Erythromycin; Female; Genotype; Gentamicins; Mastitis, Bovine; Microbial Sensitivity Tests; Penicillin G; Phenotype; Streptococcus agalactiae; Tetracycline | 2012 |
Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Citrates; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Polymyxin B; Pseudomonas aeruginosa; Sodium Citrate; Succinic Acid | 2012 |
Antibiogram pattern of oral microflora in periodontic children of age group 6 to 12 years: a clinicomicrobiological study.
Topics: Aggregatibacter actinomycetemcomitans; Amikacin; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Load; Bacteriological Techniques; Child; Clindamycin; Dental Caries; Enterococcus faecalis; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mouth; Porphyromonas gingivalis; Streptococcus mutans; Tetracycline; Vancomycin | 2013 |
Epidemiology, antibiotic consumption and molecular characterisation of Staphylococcus aureus infections--data from the Polish Neonatology Surveillance Network, 2009-2012.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; Clindamycin; Cohort Studies; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Female; Gentamicins; Gestational Age; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Poland; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors | 2015 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections | 2023 |